Studies of cognitive training in people
205 studies gave cognitive training to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves cognitive functionβ = 1.627, 95% CI 1.325–1.929 | Randomized trial12 weeks | 146 peoplemean age 69.30 years (SD, 4.08)Older adults with MCI | Research Square, Sep 30, 2026 |
up: Improves contextual Memory Test performance up: Improves metacognitive functioning up: Improves self-perception of performance | Trialseven daily individualized sessions | 20 peoplemean age: 50.2 + 5.3 yearsNeurotypical middle-aged adults | PloS one, Sep 25, 2026 |
| Randomized trial12-wk | 80 people≥65 yOlder adults; mild cognitive impairment | The Journal of nutrition, Sep 22, 2026 | |
| Trialthree-month period | 65 people57 femaleM = 75 years-old (SD = 5.20)Older participants recruited from a public institution providing care to older participants in Lisbon, Portugal | Preprints.org, Sep 8, 2026 | |
up: Increases [18F]FEOBV cholinergic binding up: Improves cognitive functionz-score change difference: + 1.53, 95% CI 1.07 to 1.99 | Randomized trial10 weeks | 93 people66% womenmean age of 71.9 yearsHealthy older adults | GeroScience, Aug 27, 2026 |
up: Improves Montreal Cognitive Assessment up: Improves Instrumental Activities of Daily Living no change: Has no effect on Montreal Cognitive Assessment | Trial12 weeks | 32 peopleolder adultsOlder adults; mild cognitive impairment, community-based group | Geriatric nursing (New York, N.Y.), Aug 21, 2026 |
no change: Has no effect on fat mass no change: Has no effect on muscle strength down: Decreases heart rate | Randomized trial12 weeks | 38 peoplemales/females = 2/16 in MJS group, males/females = 2/14 in MJ group60–75 yearsOverweight and obese older adults | PloS one, Aug 21, 2026 |
up: Increases frontal theta powermedian 4.18 to 4.67 dB (left-frontal), 4.14 to 4.76 dB (right-frontal) | Trial8-week | 20 people13 female, 7 male65.0±3.3 yearsCommunity-dwelling older adults | Brain sciences, Aug 15, 2026 |
| Randomized trial12 weeks | 162 peoplebetween 60 and 75 yearsOlder adults living in the community | Frontiers in psychology, Aug 14, 2026 | |
up: Improves executive functionsCohen's d = 0.500, 95% CI: 0.221–0.779 no change: Has no effect on global cognition no change: Has no effect on motor symptoms | Randomized trial5 weeks | 82 people87.8% (72/82) were malemean age 69.24 ± 5.90 yearsIndividuals with iRBD | Alzheimer's & dementia : the journal of the Alzheimer's Association, Aug 1, 2026 |
up: Improves cognitive function+8.60 points up: Improves executive functioning+9.88 points down: Decreases cognitive errors-1.57 errors | Trial6 months | 217 people61 to 95 years (M = 74.0 years, SD = 7.50)Adults aged 60 years or older residing in Tacna and participating in community spaces or care centers for older adults | Frontiers in public health, Jul 29, 2026 |
up: Improves attention network reaction time up: Improves stroop Color Word Test performance | Randomized trialten 20-min sessions | 55 peopleBotholder adultsOlder adults; training with concurrent active or sham stimulation | Journal of neuroengineering and rehabilitation, Jul 14, 2026 |
up: Improves cognitive functionr=0.46, median MoCA increase ~2 points | Trial | 96 peopleBothmedian age 69 yOlder adults; per-protocol analysis (adherence ≥50%) | JMIR aging, Jul 3, 2026 |
up: Improves visuospatial working memory down: Decreases audiovisual integration up: Increases P300-related audiovisual integration | Trialfive sessions | Older adults; at posttest | Frontiers in psychology, Jun 19, 2026 |
| Trialone-week | older adultsOlder adults | IET conference proceedings., Jun 1, 2026 | |
| Trial7-day | 92 peoplemean age = 66.3 years, range = 60-77Older adults | BMC geriatrics, May 28, 2026 | |
up: Improves cognitive status7/10 converted from MCI to normocognition versus 1/10, Fisher p=0.020 up: Improves executive functionmedian 512.5 to 241.0 seconds (p=0.024) up: Improves cognitive functionadjusted β=21.55 percentile points, 95% CI 1.34 to 41.75; p=0.038 | Trial9 months | 10 people>65 yearsOlder adults; in older adults with type 2 diabetes and mild cognitive impairment | Preprint, May 15, 2026 |
no change: Has no effect on usual gait speed up: Improves fast gait speed+ 0.07 m/s, p = 0.013 up: Improves balance+ 3.83 s, p = 0.015 | Randomized trial6 months | 127 peopleBoth50-87 yearsMidlife adults; Older adults | European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity, May 6, 2026 |
up: Improves cognitive functionP=.022 down: Decreases prefrontal cortex activationP=.015 vs control | Randomized trial8 weeks | 60 people>65 yearsOlder adults; mild cognitive impairment or mild dementia | Archives of physical medicine and rehabilitation, May 2, 2026 |
| Randomized trial | Older adults | Multivariate behavioral research, May 1, 2026 | |
up: Improves balance up: Improves cognitive function | Randomized trial12-week | 65 peopleolder adultsMidlife adults; Older adults; in older adults with better hearing | PloS one, Apr 29, 2026 |
up: Improves cognitive functionp = 0.000 | Trialeight sessions, each lasting 30–60 minutes | 50 peoplepre-elderly and older adultsOlder adults | Jurnal Penelitian Pendidikan IPA, Apr 25, 2026 |
no change: Has no effect on RBANS scoreaOR = 0.86; 95% CI: 0.45, 1.65 | Randomized trial4 months | 152 peopleBoth65 years or olderOlder adults; older ED patients hospitalized with delirium | Journal of the American Geriatrics Society, Apr 17, 2026 |
up: Improves cognitive function100% of participants | Trialsix weeks (12 sessions) | 5 people64-73Older adults | Journal of Associated Medical Sciences, Apr 3, 2026 |
| Randomized trialsix sessions over three weeks | older adultsOlder adults | Cognitive, affective & behavioral neuroscience, Apr 2, 2026 | |
| Trialthree months | older adultsOlder adults | Scientific reports, Mar 31, 2026 | |
no change: Has no effect on heart rate variability | Randomized trial8 repetitions of 45” performing burpees with a resting period of 45” between repetitions | 63 peopleMen24.3 ± 4.2 yearsDuring HIIT resting periods | Research Square, Mar 26, 2026 |
up: Improves cognitive functionp = 0.044 no change: Has no effect on Hospital Anxiety and Depression Scale | Trial6-month | 41 people60-93Older adults; older adults with cognitive impairment or dementia | Digital health, Feb 23, 2026 |
up: Improves prospective memory no change: Has no effect on executive function | Randomized trial4 weeks | 30 peopleParkinson's disease with mild cognitive impairment | Rehabilitation psychology, Feb 16, 2026 |
up: Improves subjective cognitive impairment no change: Has no effect on Symbol Digit Modalities Test | Randomized trial6 months | 46 peopleMultiple sclerosis with cognitive impairment | Journal of neurology, Jan 16, 2026 |
| Randomized trial8 weeks | 47 people65 and olderOlder adults; elderly individuals with mild cognitive impairment | BMC geriatrics, Jan 10, 2026 | |
| Trial12 months | 198 peopleelderlyOlder adults; Patient cohorts | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, Jan 1, 2026 | |
up: Improves cognitive functionp<0.001 | Treated cohort10 sessions | median age 72 yearsOlder adults | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, Jan 1, 2026 |
down: Decreases cognitive intra-individual variability down: Decreases variability down: Decreases hit reaction time standard deviation | Randomized trial20 hours | 118 peopleBoth40 to 70Midlife adults; Older adults; in people with HIV | GSA 2025 abstract, Dec 31, 2025 |
down: Decreases memory complaintsfrom 94.74%, 85%, and 6.5% to 15%, 20%, and 0% up: Increases mnemonic strategy use up: Improves memory performance | Trial9-month follow-up | 55 peopleolder adultsOlder adults; Aβ+ and Aβ- amnestic MCI and healthy controls | AAIC 2025 abstract, Dec 26, 2025 |
up: Improves working memory down: Decreases depressive symptoms | Randomized trial18 months | 189 peopleolder adultsOlder adults; cognitively unimpaired | AAIC 2025 abstract, Dec 25, 2025 |
no change: Has no effect on Alzheimer's disease blood biomarkers | Trial6 months | 344 peopleBoth73.83 years oldOlder adults; mild cognitive impairment | AAIC 2025 abstract, Dec 25, 2025 |
| Trial8 weeks | 151 people69.71 yearsOlder adults | AAIC 2025 abstract, Dec 23, 2025 | |
up: Improves attention allocationp = .02; p = .03 up: Improves executive functions composite scorep = .03 no change: Has no effect on mood | Randomized trial13 sessions (1 hour each, 3 times a week) | 38 peopleM = 65.8Older adults; cognitively healthy older adults | AAIC 2025 abstract, Dec 23, 2025 |
up: Improves cognitive function43.5 % to 84.6 % vs 8.3 % to 22.2 % reliable improvement up: Improves activities of daily livingmoderate effect size | Randomized trial12-week | Older adults; rural older adults with dementia | Geriatric nursing (New York, N.Y.), Nov 23, 2025 |